NEDL1 (NEDD4-like ubiquitin protein ligase-1) is a newly identified HECT-type E3 ubiquitin protein ligase highly expressed in favorable neuroblastomas as compared with unfavorable ones. In this study, we found that NEDL1 cooperates with p53 to induce apoptosis. During cisplatin (CDDP)-mediated apoptosis in neuroblastoma SH-SY5Y cells, p53 was induced to accumulate in association with an increase in expression levels of NEDL1. Enforced expression of NEDL1 resulted in a decrease in number of G418-resistant colonies in SH-SY5Y and U2OS cells bearing wild-type p53, whereas NEDL1 had undetectable effect on p53-deficient H1299 and SAOS-2 cells. Similarly, enforced expression of NEDL1 increased number of U2OS cells with sub-G1 DNA content. Co-immunoprecipitation and in vitro binding assays revealed that NEDL1 binds to the COOH-terminal region of p53. Luciferase reporter assay showed that NEDL1 has an ability to enhance the transcriptional activity of p53. Small interfering RNAmediated knockdown of the endogenous NEDL1 conferred the resistance of U2OS cells to adriamycin. It is noteworthy that NEDL1 enhanced pro-apoptotic activity of p53 in its catalytic activity-independent manner. Taken together, our present findings suggest that functional interaction of NEDL1 with p53 might contribute to the induction of apoptosis in cancerous cells bearing wildtype p53.
Introduction
NEDL1 (NEDD4-like ubiquitin protein ligase-1), which has been identified as a novel gene expressed significantly at high levels in favorable neuroblastomas relative to unfavorable ones, encodes HECT-type E3 ubiquitin ligase and is detected specifically in human neuronal tissues (Miyazaki et al., 2004) , suggesting that NEDL1 might be involved in the regulation of the spontaneous regression of favorable neuroblastomas caused by apoptosis and/or neuronal differentiation. According to our previous findings, NEDL1 ubiquitinated mutant forms of SOD1 (superoxide dismutase-1) as well as Dvl-1 (Dishevelled-1), thereby promoting their proteasome-dependent degradation (Miyazaki et al., 2004) . SOD1 mutations have been detected in a certain subset of patients with familial amyotrophic lateral sclerosis, which is one of the fatal neurological diseases in human, and mutant SOD1 aggregates to form insoluble macromolecular protein complexes in motor neurons and astrocytes (Cluskey and Ramsden, 2001) , suggesting that the accumulation of misfolded proteins generates cellular stresses to induce neuronal cell death. However, the precise molecular mechanisms behind the possible contribution of NEDL1 to apoptosis in motor neurons remain elusive.
As described previously (Gonzalez de Aguilar et al., 2000) , pro-apoptotic Bax, which is one of the direct targets of tumor suppressor p53 (Roos and Kaina, 2006) , accumulated in central nervous system regions in patients with amyotrophic lateral sclerosis. In support of this notion, p53 was induced in central nervous system regions in patients and also in model mice with amyotrophic lateral sclerosis (Martin, 2000) , indicating that p53-mediated pro-apoptotic pathway plays an important role in the regulation of neuronal apoptosis. p53 is a nuclear transcription factor that induces cell cycle arrest and/or apoptosis. Under normal conditions, p53 is kept at extremely low level. The expression of p53 is regulated largely at protein level. For example, E3 ubiquitin ligase MDM2 inhibits transactivation activity of p53 and also promotes its ubiquitination-mediated proteasomal degradation (Vousden and Lu, 2002) . In response to genotoxic stresses, p53 is induced to be converted from the latent form to the active one through the post-translational modifications such as phosphorylation and acetylation, and thereby transactivating its direct target genes implicated in cell cycle arrest and/or apoptosis including p21 WAF1 , MDM2, Bax, Puma, Noxa and p53AIP1 (Vousden and Lu, 2002) . Accumulating evidence strongly suggests that its transactivation activity is tightly linked to its pro-apoptotic function (Pietenpol et al., 1994) . Consistent with this notion, majority of loss-of-function mutations of p53 in a variety of primary human tumors is detected within its DNA-binding domain (Hollstein et al., 1991; Levine et al., 1994) and p53-deficient mice developed spontaneous tumors (Donehower et al., 1992) .
In the present study, we found that NEDL1 binds to the COOH-terminal region of p53 and enhances its transcriptional activity as well as pro-apoptotic function in its catalytic activity-independent manner. Our present findings suggest that NEDL1 plays a pivotal role in the induction of apoptosis in cancerous cells bearing wildtype p53 through the interaction with p53 and also might provide a novel insight into understanding neuronal dysfunction.
Results
NEDL1 has a pro-apoptotic function As described previously (Miyazaki et al., 2004) , we cloned a novel gene termed NEDL1 from the oligocapping cDNA libraries prepared from a mixture of fresh primary neuroblastoma tissues that underwent spontaneous regression (Nakagawara and Ohira, 2004) . NEDL1 was highly expressed in favorable neuroblastomas as compared with unfavorable ones and significantly associated with better prognosis in neuroblastoma (Supplementary Figure S1) . To examine the expression levels of NEDL1 in response to DNA damage, human neuroblastoma SH-SY5Y cells bearing wild-type p53 were exposed to 20 mM of cisplatin (CDDP). At the indicated time periods, cells were subjected to terminal deoxynucleotidyl transferasemediated dUTP-biotin nick end labeling (TUNEL) staining. As shown in Figure 1a , SH-SY5Y cells underwent apoptosis in a time-dependent manner. We then analysed the expression patterns of NEDL1 and p53 in response to CDDP. As shown in Figures 1b and c, p53 was induced to accumulate at protein level but not at mRNA level and CDDP treatment promoted phosphorylation of p53 at Ser-15 in association with a significant upregulation of various p53 target genes such as p21
WAF1
, Bax and Noxa. It is noteworthy that NEDL1 increased at both mRNA and protein levels in SH-SY5Y cells exposed to CDDP in a time-dependent manner. NEDL1 was also upregulated in p53-deficient human lung carcinoma H1299 cells in response to CDDP (Figure 1d ), indicating that NEDL1 might not be a direct target of p53. Since a correlation between expression levels of NEDL1 and p53 was observed in SH-SY5Y cells treated with CDDP, it is likely that there could exist a functional interaction between them during DNA damage-mediated apoptotic response.
To confirm this notion, we performed colony formation assay. p53-proficient SH-SY5Y, human osteosarcoma U2OS, p53-deficient human lung carcinoma H1299 and human osteosarcoma SAOS-2 cells were transfected Figure 1 NEDL1 is induced to accumulate in response to CDDP. (a) CDDP-mediated apoptosis. SH-SY5Y cells were treated with CDDP (20 mM). Cells were then stained with an in situ cell death detection kit followed by mounting with 4 0 ,6-diamidino-2-phenylindole-containing mounting medium. The number of TUNEL-positive cells was scored. Results were expressed as means ± s.d. of three independent experiments. (b and c) Expressions of NEDL1 and p53 in response to CDDP. Total RNA and cell lysates were prepared from SH-SY5Y cells exposed to CDDP for the indicated time periods and subjected to RT-PCR (b) and immunoblotting (c), respectively. (d) NEDL1 is induced in p53-deficient H1299 cells exposed to CDDP. H1299 cells were treated with 25 mM of CDDP. At the indicated time points, total RNA was prepared and analysed for the expression levels of NEDL1 by RT-PCR. GAPDH was used as an internal control. CDDP, cisplatin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; NEDL1, NEDD4-like ubiquitin protein ligase-1; RT-PCR, reverse transcription-PCR; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling.
NEDL1 cooperates with p53 to induce apoptosis Y Li et al with empty plasmid or with expression plasmid for NEDL1. Following 2 weeks of selection with G418, drug-resistant colonies were stained and photographed. As shown in Figures 2a and b , enforced expression of NEDL1 caused a significant decrease in the number of drug-resistant colonies in p53-proficient SH-SY5Y and U2OS cells relative to control cells, whereas NEDL1 had undetectable effects on p53-deficient H1299 and SAOS-2 cells, indicating that NEDL1 induces cell cycle arrest and/or apoptosis in cells carrying wild-type p53.
To address whether NEDL1 could cooperate with p53 to induce cell cycle arrest and/or apoptosis, we checked NEDL1-mediated proteolytic cleavage of caspase-3. For this purpose, expression plasmid for NEDL1 was introduced into the indicated cells. As shown in Figure 3a , NEDL1-mediated proteolytic cleavage of caspase-3 was detectable in SH-SY5Y and U2OS cells, but not in H1299 and SAOS-2 cells. Furthermore, enforced expression of NEDL1 resulted in an increase in the number of U2OS cells with sub-G1 DNA content (Figure 3b ), whereas NEDL1 had negligible effects on SAOS-2 cells (Figure 3c ). Since U2OS cells expressed wild-type p53, these findings suggest that NEDL1 induces apoptosis in a p53-dependent manner.
Interaction between NEDL1 and p53
To determine whether NEDL1 could interact with p53, COS7 cells were transfected with NEDL1 expression plasmid. As shown in Figure 4a , the anti-NEDL1 immunoprecipitates contained endogenous p53. To further confirm this issue, cell lysates prepared from U2OS cells exposed to CDDP were immunoprecipitated with normal rabbit serum or with anti-NEDL1 antibody and analysed by immunoblotting with anti-p53 antibody. As shown in Figure 4b , the anti-NEDL1 immunoprecipitates contained endogenous p53, suggesting that NEDL1 associates with endogenous p53 in cells. In contrast to wild-type p53, mutant form of p53 was not co-immunoprecipitated with NEDL1 ( Figure 4c ). To identify the region(s) of p53 responsible for the interaction with NEDL1, we performed in vitro pull-down assay using the indicated radio-labeled p53 deletion mutants. As clearly shown in Figure 4d , full-length p53, p53(1-353) and p53(102-393) were co-immunoprecipitated with NEDL1, whereas remaining p53 deletion mutants including p53(1-292) and p53(1-102) were not. Under our experimental conditions, other p53 family members such as p73 and p63 failed to be coimmunoprecipitated with NEDL1 (data not shown). These results suggest that NEDL1 specifically interacts with COOH-terminal region of p53 (amino-acid residues 293-353) and might modulate p53 function.
NEDL1 enhances the transcriptional activity of p53 Next, we sought to examine a possible effect of NEDL1 on the transcriptional activity of p53. H1299 cells were co-transfected with a constant amount of p53 expression plasmid, together with p53-responsive p21 WAF1 or Bax luciferase reporter construct in the presence or absence of increasing amounts of NEDL1 expression plasmid. As shown in Figures 5a and b , enforced expression of NEDL1 enhanced p53-mediated transactivation toward p21
WAF1
and Bax promoters in a dose-dependent manner. Similarly, luciferase activities driven by p21 WAF1 promoter were increased by NEDL1 in U2OS cells (Figure 5c ). In support of these results, reverse transcription-polymerase chain reaction (RT-PCR) analysis showed that enforced expression of NEDL1 led to a significant increase in expression levels of endogenous p21 promoter region, whereas NEDL1 alone is not recruited onto p21 WAF1 promoter region (Figure 5e ), indicating that NEDL1 might cooperate with p53 to directly induce the transcription of p53 target genes.
NEDL1 enhanced the pro-apoptotic activity of p53 independent of its ubiquitin ligase activity Since NEDL1 has an intrinsic E3 ubiquitin ligase activity (Miyazaki et al., 2004) , these results prompted us to examine whether NEDL1 could ubiquitinate p53. In spite of our extensive efforts, we could not detect NEDL1-mediated ubiquitination of p53 (Supplementary Figure S2 ). Under our experimental conditions, NEDL1 efficiently ubiquitinated Dvl-1 as described previously (Miyazaki et al., 2004) , whereas HECT(À) mutant failed to ubiquitinate Dvl-1. To extend these observations, we examined a possible effect of NEDL1 catalytic activity on pro-apoptotic function of p53. H1299 cells were cotransfected with a constant amount of expression plasmid for p53 together with or without increasing amounts of wild-type NEDL1 or mutant form of NEDL1 lacking HECT domain termed HECT(À) (Figure 6a ). Following 2 weeks of selection with G418 (400 mg ml À1 ), drug-resistant colonies were stained with Giemsa's solution. Enforced expression of p53 decreased the number of drug-resistant colonies as compared with that in control cells ( Figure 6b ). As expected, coexpression of p53 plus wild-type NEDL1 or HECT(À) mutant led to a dramatic decrease in the number of drug-resistant colonies in a dose-dependent manner relative to that in cells expressing p53 alone. In vitro pull-down assay demonstrated that HECT(À) mutant, but not CW linker, retains an ability to interact with p53 ( Figure 6c ). In addition, CW linker had negligible effects on the transcriptional activity of p53 (Supplementary Figure S3 ). Thus, it is likely that NEDL1 enhances the transcriptional as well as pro-apoptotic function of p53 in its catalytic activity-independent manner. siRNA-mediated knockdown of endogenous NEDL1 confers resistance of U2OS cells to adriamycin To address the physiological role of endogenous NEDL1 in response to DNA damage, we designed small interfering RNAs (siRNAs) against NEDL1 termed nos. 1, 2, 3 and 4. U2OS cells were transfected with the indicated siRNAs. As shown in Figure 7a , nos. 2, 3 and 4 siRNAs successfully knocked down the endogenous NEDL1. We then used nos. 2 and 4 siRNAs for further experiments.
To examine the possible effect of siRNA targeting NEDL1 on the sensitivity to adriamycin (ADR), U2OS cells were transfected with control siRNA, no. 2 or 4 siRNA. Twenty-four hours after transfection, cells were NEDL1 cooperates with p53 to induce apoptosis Y Li et al exposed to the indicated concentrations of ADR for 24 h followed by fluorescence-activated cell sorter (FACS) analysis. As shown in Figure 7b , U2OS cells transfected with control siRNA underwent apoptosis in a dosedependent manner. In contrast, the number of cells with sub-G1 DNA content in response to ADR was significantly decreased in U2OS cells transfected with siRNAs against NEDL1 relative to cells expressing control siRNA. Similarly, siRNA-mediated knockdown of endogenous NEDL1 led to a remarkable decrease in the number of apoptotic cells caused by ADR in a timedependent manner ( Figure 7c ). Next, we determined whether siRNA-mediated knockdown of endogenous NEDL1 could inhibit the transcriptional activation of p53 target genes in response to ADR. U2OS cells were transfected with the indicated siRNAs. Twenty-four hours after transfection, cells were treated with ADR for 24 h. As shown in Figure 8a , ADR treatment induced the accumulation of p53 and phosphorylated form of p53 at Ser-15. However, siRNA-mediated knockdown of endogenous NEDL1 had negligible effects on amounts of p53 and phosphorylated form of p53 at Ser-15 in response to ADR, suggesting that their interaction does not affect the stability of p53 in response to DNA damage. It is noteworthy that expression levels of Noxa increased in cells exposed to ADR, whereas ADR-mediated upregulation of Noxa was markedly inhibited in NEDL1-knocked down U2OS cells. RT-PCR analysis also demonstrated that siRNA-mediated knockdown of endogenous NEDL1 reduces the transcription of p53 target genes such as Noxa and Puma induced by ADR (Figure 8b ). ADR treatment had undetectable effects on p53 (data not shown). Intriguingly, NEDL1 increased the acetylation levels of p73 (Figure 8c ). Taken together, our present results suggest that NEDL1 has an ability to enhance the transcriptional and pro-apoptotic activities of p53 through the interaction without affecting its stability.
Discussion
In the present study, we have found that a novel HECTtype E3 ubiquitin ligase NEDL1 has the ability to cooperate with p53 to induce apoptosis.
During CDDP-mediated apoptosis in SH-SY5Y cells carrying wild-type p53, expression levels of NEDL1 correlated with those of p53. Expression levels of NEDL1 were higher in favorable neuroblastoma than those in unfavorable neuroblastoma. Favorable neuroblastoma undergoes spontaneous regression through NEDL1 cooperates with p53 to induce apoptosis Y Li et al apoptosis and/or neuronal differentiation (Kitanaka et al., 2002) . In contrast to other human tumors, p53 is rarely mutated in neuroblastoma (Moll et al., 1995) . Thus, it is likely that functional interaction between NEDL1 and p53 might contribute to induction of spontaneous regression caused by apoptosis of favorable neuroblastoma bearing wild-type p53. , 2006) . In accordance with this notion, enforced expression of NEDL1 resulted in an increase in acetylation levels of p53. Thus, it is possible that the interaction between NEDL1 and p53 might help to expose DNA-binding domain of p53 through the induction of acetylation of p53, and thereby enhance its transcriptional activity. However, the precise molecular mechanisms behind NEDL1-mediated induction of acetylation of p53 remained unclear. Further studies should be necessary to address this issue. Although we found that NEDL1 has an intrinsic E3 ubiquitin ligase activity (Miyazaki et al., 2004) , our extensive efforts failed to detect NEDL1-mediated ubiquitination of p53 and enforced expression of NEDL1 had undetectable effects on the stability of endogenous p53 (data not shown). Under our experimental conditions, MDM2 promoted ubiquitinationmediated degradation of p53 (data not shown). NEDL1 and mutant form of NEDL1 lacking its catalytic HECT domain had an ability to decrease the number of drugresistant colonies in H1299 cells co-transfected with p53 expression plasmid. Like wild-type NEDL1, this NEDL1 mutant retained an ability to interact with Luciferase reporter assays. H1299 cells were co-transfected with 25 ng of expression plasmid for p53, 100 ng of luciferase reporter construct containing p53-responsive element derived from p21 WAF1 (a) or Bax (b) promoter and 10 ng of Renilla luciferase plasmid (pRL-TK) together with or without increasing amounts of expression plasmid for NEDL1 (475 and 875 ng). Total amount of plasmid DNA per transfection was kept constant (1 mg) with pcDNA3. Forty-eight hours after transfection, cell lysates were prepared and their luciferase activity was measured. Data were normalized to the Renilla luciferase activity. (c) Luciferase reporter assays. U2OS cells were co-transfected with 100 ng of luciferase reporter construct containing p53-responsive element derived from p21 WAF1 promoter and 10 ng of pRL-TK together with or without increasing amounts of expression plasmid for NEDL1 (400, 800 and 1000 ng). Forty-eight hours after transfection, cell lysates were prepared and their luciferase activity was measured as described above. (d) RT-PCR analysis. H1299 cells were co-transfected with a constant amount of p53 expression plasmid (0.1 mg) along with or without NEDL1 expression plasmid (1.9 mg). Forty-eight hours after transfection, total RNA was isolated and subjected to RT-PCR analysis. GAPDH was used as an internal control. (e) ChIP assay. The increased binding of p53 to the promoter region of p21 WAF1 caused by NEDL1 was demonstrated by ChIP assay with chromatin isolated from H1299 cells transfected with the indicated combinations of expression plasmids. As a control, PCR was performed on chromatin fragments isolated both before (input) and after (IP) immunoprecipitation with monoclonal anti-p53 antibody or with normal mouse serum (NMS) (upper panels). Middle panels show the increased binding of endogenous p53 to p21 WAF1 promoter in the presence of NEDL1. Crosslinked chromatin isolated from U2OS cells transfected with or without NEDL1 expression plasmid exposed to adriamycin was subjected to ChIP assay. Lower panels show ChIP assay using crosslinked chromatin prepared from H1299 cells transfected with the indicated combinations of expression plasmids. Crosslinked chromatin was immunoprecipitated with polyclonal anti-NEDL1 or with NRS and subjected to PCR. CDDP, cisplatin; ChIP, chromatin immunoprecipitation; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; NEDL1, NEDD4-like ubiquitin protein ligase-1; NRS, normal rabbit serum; RT-PCR, reverse transcriptase-PCR.
NEDL1 cooperates with p53 to induce apoptosis Y Li et al p53 but not ubiquitinate p53. Thus, it is conceivable that the interaction of NEDL1 with p53 suppresses the inhibitory effect of COOH-terminal region of p53 on its function in its catalytic activity-independent manner.
In contrast to p53, NEDL1 did not interact with other p53 family members such as p73 and p63 (data not shown). Intriguingly, we reported that NEDL2, a close relative to NEDL1, binds to PY motif of p73 and Figure 7 siRNA-mediated knockdown of endogenous NEDL1 confers resistance of U2OS cells to ADR. (a) siRNA-mediated knockdown of endogenous NEDL1. U2OS cells were transfected with control siRNA (À), siRNA against NEDL1 termed no. 1, 2, 3 or 4 siRNA. Forty-eight hours after transfection, total RNA was prepared and subjected to reverse transcriptase-PCR. GAPDH was used as an internal control. (b) U2OS cells were transfected with control siRNA, no. 2 or 4 siRNA. Twenty-four hours after transfection, cells were exposed to the indicated concentrations of ADR for 24 h and then cell cycle distributions of cells were analysed by FACS. (c) U2OS cells were transfected with control siRNA, no. 2 or 4 siRNA. Twenty-four hours after transfection, cells were treated with ADR (1 mM). At the indicated time periods, cell cycle distributions of cells were analysed by FACS. ADR, adriamycin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; NEDL1, NEDD4-like ubiquitin protein ligase-1; siRNA, small interfering RNA.
NEDL1 cooperates with p53 to induce apoptosis Y Li et al promotes ubiquitination of p73 (Miyazaki et al., 2003) . According to our previous results, NEDL2-mediated ubiquitination of p73 increased the stability and activity of p73, raising a possibility that ubiquitination does not always act as a degradation signal. Consistent with our results, ubiquitination was required for the transcriptional activity of c-myc (Adhikary et al., 2005) . It is noteworthy that NEDL2 did not interact with p53 that lacks PY motif and had negligible effects on p53 (Miyazaki et al., 2003) , indicating that NEDL1 family members have a differential effect on p53 family members. In this regard, it is of interest to examine whether there could exist a functional interaction between NEDL1 family members and p63 that contains PY motif. Several lines of evidence suggest that pro-apoptotic p53 signaling pathway is involved in motor neuron death associated with amyotrophic lateral sclerosis through an upregulation of pro-apoptotic Bax (Ekegren et al., 1999; Gonzalez de Aguilar et al., 2000; Martin and Liu, 2002) . Recently, it has been shown that Noxa is one of the critical mediators of p53-dependent motor neuron death (Kiryo-Seo et al., 2005) . These observations suggest that pro-apoptotic p53 signaling pathway plays a causable role in the regulation of neuronal cell death. Thus, it is likely that NEDL1 is involved in the regulation of this cellular process through the interaction with p53.
As described previously (Miyazaki et al., 2004) , we found that Dvl-1, a highly conserved cytoplasmic phosphoprotein implicated in Wnt signaling pathway, is one of the physiological targets of NEDL1. On the basis of our previous results, NEDL1 ubiquitinated Dvl-1 and induced its degradation in a proteasomedependent manner. It has been well documented that Dvl-1 increases the stability of b-catenin through the inhibition of the catalytic activity of glycogen synthase kinase-3b (GSK-3b) (Kishida et al., 2001; Lee et al., 2001; Hino et al., 2003) . In addition, GSK-3b facilitated staurosporine-mediated apoptosis in SH-SY5Y cells (Bijur et al., 2000) and also contributed to neuronal apoptosis induced by trophic withdrawal (Hetman et al., 2000) . Consistent with these results, specific inhibition of GSK-3b activity by a small chemical compound protected primary neuron from apoptosis (Cross et al., 2001) . These results suggest that GSK-3b activity is closely involved in the induction of neuronal cell death. It is worth noting that GSK-3b interacts with p53 in response to DNA damage and enhances pro-apoptotic function of p53 (Watcharasit et al., 2002) . Taken together, there exists a functional interaction among NEDL1, Dvl-1, p53 and GSK-3b, which might play a pivotal role at least in part in the regulation of apoptosis in response to DNA damage. Further studies should be necessary to address this issue.
Materials and methods
Cell culture and transfection COS7, U2OS and SAOS-2 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% of heatinactivated fetal bovine serum (Invitrogen, Carlsbad, CA, USA), penicillin (100 IU ml À1 ) and streptomycin (100 mg ml
À1
). p53-deficient H1299 and SH-SY5Y cells were grown in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum and antibiotic mixture. Cells were cultured at 37 1C in a water-saturated atmosphere of 95% air and 5% CO 2 . Transient transfection was performed using LipofectAMINE 2000 transfection reagent (Invitrogen) according to the manufacturer's instructions.
Immunoblotting and immunoprecipitation
For immunoblotting, cells were lysed in a lysis buffer containing 25 mM Tris-Cl pH 7.5, 137 mM NaCl, 2.7 mM RT-PCR analysis. U2OS cells were treated as in (a), and total RNA was prepared and subjected to RT-PCR. (c) NEDL1-mediated increase in acetylation levels of p53. U2OS cells were transfected with empty plasmid or with expression plasmid for NEDL1. Forty-eight hours after transfection, cell lysates were immunoprecipitated with monoclonal anti-p53 antibody. The immunoprecipitates were analysed by immunoblotting with polyclonal anti-acetyl-Lys antibody (New England Biolabs, Ipswich, MA, USA). Expression levels of total p53, NEDL1 and actin were also examined. ADR, adriamycin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; NEDL1, NEDD4-like ubiquitin protein ligase-1; RT-PCR, reverse transcriptase-PCR; siRNA, small interfering RNA.
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KCl, 1% Triton X-100 and protease inhibitor cocktail. Equal amounts of cell lysates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto Immobilon-P membranes (Millipore, Bedford, MA, USA). The transferred membranes were incubated with monoclonal anti-p21 WAF1 (Ab-1, Oncogene Research Products, Cambridge, MA, USA), monoclonal anti-p53 (DO-1, Oncogene Research Products), monoclonal anti-Noxa (ab13654, Abcom, Cambridge, UK), polyclonal anti-Bax (Cell Signaling, Beverly, MA, USA), polyclonal anti-caspase-3 (Calbiochem, San Diego, CA, USA), polyclonal anti-phosphorylated p53 at Ser-15 (Cell Signaling), polyclonal anti-NEDL1 or with polyclonal anti-actin (20-33, Sigma, St Louis, MO, USA) antibody followed by incubation with the appropriate HRP-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Bound antibodies were detected by ECL system (Amersham Biosciences, Piscataway, NJ, USA). For immunoprecipitation, 1 mg of protein was incubated with protein G-Sepharose beads (Amersham Biosciences). The precleaned lysates were incubated with polyclonal anti-NEDL1 antibody for 2 h at 4 1C and immunocomplexes were precipitated with protein GSepharose beads for additional 1 h at 4 1C. The immunocomplexes were washed three times with the lysis buffer, eluted from beads by adding 2 Â SDS sample buffer, resolved by SDS-PAGE and subjected to immunoblotting with polyclonal anti-NEDL1 or with monoclonal anti-p53 (DO-1, Oncogene Research Products) antibody.
In vitro binding assay Wild-type p53 and its deletion mutants were expressed in vitro using a T7 Quick Coupled Transcription/Translation System (Promega, Madison, WI, USA) in the presence of [ 35 S]methionine according to the manufacturer's recommendations. Cell lysates prepared from COS7 cells transfected with the expression plasmid encoding NEDL1 were mixed and incubated overnight at 4 1C. Reaction mixtures were then immunoprecipitated with the anti-NEDL1 antibody. Immunoprecipitates were washed extensively with the lysis buffer and resolved by SDS-PAGE. The gels were dried and subjected to autoradiography.
TUNEL assay SH-SY5Y cells were grown on coverslips and treated with CDDP (20 mM). At the indicated time periods after the treatment with CDDP, cells were fixed in 4% paraformaldehyde and apoptotic cells were detected by using an in situ cell death detection Kit (Roche Molecular Biochemicals, Mannheim, Germany) according to the manufacturer's protocol. The coverslips were mounted with 4 0 ,6-diamidino-2-phenylindole-containing mounting medium (Vector Laboratories, Burlingame, CA, USA) and observed under a Fluoview laser scanning confocal microscope (Olympus, Tokyo, Japan).
FACS analysis U2OS and SAOS-2 cells were transfected with the expression plasmid for NEDL1. Forty-eight hours after transfection, floating and attached cells were collected, washed in phosphate-buffered saline and fixed in 70% ethanol at À20 1C. Following incubation in phosphate-buffered saline containing 40 mg ml À1 of propidium iodide and 200 mg ml À1 of RNase A for 1 h at room temperature in the dark, stained nuclei were analysed on a FACScan machine (Becton Dickingson, Mountain View, CA, USA).
RT-PCR
SH-SY5Y cells were treated with CDDP (20 mM). At the indicated time periods after the treatment, total RNA was prepared using an RNeasy mini kit (Qiagen, Valencia, CA, USA). Five micrograms of total RNA were employed to synthesize the first-strand cDNA by using random primers and SuperScript II reverse transcriptase (Invitrogen) according to the manufacturer's instructions. The resultant cDNA was subjected to the PCR-based amplification. The list of primer sets used will be provided upon request. The expression of glyceraldehyde-3-phosphate dehydrogenase was measured as an internal control. The PCR products were subjected to agarose gel electrophoresis and visualized by ethidium bromide staining.
Luciferase reporter assay H1299 cells were allowed to adhere overnight in 12-well cell culture plates at a final density of 50 000 cells per well. Cells were then co-transfected with 25 ng of the p53 expression plasmid, 100 ng of the p53-responsible luciferase reporter construct (p21 WAF1 or Bax) and 10 ng of pRL-TK Renilla luciferase cDNA together with or without increasing amounts of the NEDL1 expression plasmid (475 and 875 ng). Total amount of plasmid DNA per transfection was kept constant (1 mg) with an empty plasmid pcDNA3 (Invitrogen). Fortyeight hours after transfection, cells were lysed and both the firefly and Renilla luciferase activities were measured with dual-luciferase reporter assay system (Promega), according to the manufacturer's instructions. The firefly luminescence signal was normalized based on the Renilla luminescence signal.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation assay was performed according to the protocol provided by Upstate Biotechnology (Lake Placid, NY, USA). In brief, H1299 cells were transfected with the expression plasmid for p53 together with or without the expression plasmid for NEDL1. Forty-eight hours after transfection, cells were treated with 1% formaldehyde at 37 1C for 15 min. After being washed with ice-cold phosphatebuffered saline, cells were suspended with 200 ml of SDS lysis buffer (1% SDS, 10 mM EDTA and 50 mM Tris-HCl, pH 8.1) on ice for 10 min. Lysates were sonicated and insoluble materials were removed by centrifugation. Supernatants were then precleared with 20 ml of protein A agarose beads that had been preabsorbed with salmon sperm DNA at 37 1C for 30 min. The precleared chromatin solutions were immunoprecipitated with normal mouse serum or with anti-p53 antibody at 4 1C overnight, followed by incubation with 60 ml of protein A agarose beads for 1 h at 4 1C. Samples were eluted with 200 ml of the elution buffer (1% SDS and 0.1 M NaHCO 3 ) and then crosslinks were reversed by heating them at 65 1C for 6 h. Chromatin-associated proteins were digested with proteinase K at 45 1C for 1 h, and immunoprecipitated DNA was purified by using QIAquick PCR purification kit (Qiagen) according to the manufacturer's instructions. Purified DNA was analysed by PCR-based amplification. The primer set used to detect p21 WAF1 promoter was as follows: 5 0 -CACCTTTCACCAT TCCCCTA-3 0 (forward) and 5 0 -GCAGCCCAAGGACAAA ATAG-3 0 (reverse). Colony formation assay H1299, SH-SY5Y, U2OS and SAOS-2 cells were seeded at a final density of 1 Â 10 5 cells per six-well dish and allowed to attach overnight. Cells were then co-transfected with the indicated combinations of the expression plasmids. Total amount of plasmid DNA per transfection was kept constant (2 mg) with pcDNA3. Forty-eight hours after transfection, cells were transferred to the fresh medium containing G418 (400 mg ml À1 ). After 14 days, viable colonies were washed in phosphate-buffered saline and stained with Giemsa's solution.
